Read More

Viridian Therapeutics Appoints Stephen Mahoney As New Chief Executive Officer, Unveils Next Generation FcRn Inhibitor Programs And Announces $185M Private Placement Financing

– Stephen Mahoney appointed President and Chief Executive Officer –– Potential best-in-class subcutaneous and intravenous thyroid eye disease (TED) programs targeting insulin-like growth factor 1 receptor (IGF-1R) remain

VRDN

Read More

‘GM Matches Ford’s 25% Salary Increase In Latest Offer To UAW; Other Details Still Being Hashed Out, People Familiar Say; GM Made Latest Contract Offer To Union In Predawn Hours’ – Bloomberg News

https://www.bloomberg.com/news/articles/2023-10-27/gm-matched-ford-s-25-salary-increase-in-latest-contract-offer-to-uaw?utm_content=business&utm_campaign=socialflow-organic&utm_medium=social&cmpid=socialflow-

GM